LINE

    Text:AAAPrint
    Photo

    COVID-19 testing lab built with air-inflated structure goes into trial operation in Beijing(1/18)

    2020-06-23 09:45:08 Xinhua Editor :Li Yan
    1

    Photo taken on June 22, 2020 shows a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Members of staff work at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Members of staff work at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    A member of staff works at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Members of staff make preparations at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Photo taken on June 22, 2020 shows a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Members of staff work at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Members of staff work at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Photo taken on June 22, 2020 shows a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    A staff member works at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Devices are tested at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Members of staff work at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Members of staff work at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Members of staff work at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Members of staff work at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Members of staff work at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Photo taken on June 22, 2020 shows a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    Members of staff work at a COVID-19 testing lab built with an air-inflated structure in Daxing District, Beijing, capital of China, June 22, 2020. A COVID-19 testing lab built with an air-inflated structure went into trial operation on Monday at a sports venue in Daxing District of Beijing to address the city's rising demand for nucleic acid tests after a cluster of infections were confirmed recently. The mobile Huoyan (Fire Eye) laboratory was built in two days over the weekend to accommodate 14 automated COVID-19 testing machines provided by Chinese biotech company BGI Genomics based in the city of Shenzhen, south China's Guangdong Province. (Xinhua/Peng Ziyang)

    LINE
      ${visuals_2}
      ${visuals_3}
      ${new_video_hd2}
      ${new_video_hd3}
    LINE
    Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
    Copyright ©1999-2020 Chinanews.com. All rights reserved.
    Reproduction in whole or in part without permission is prohibited.
    主站蜘蛛池模板: 伊通| 翁源县| 阿拉善左旗| 高陵县| 海南省| 白朗县| 岑溪市| 万宁市| 张家界市| 凌海市| 明星| 平陆县| 中山市| 章丘市| 威远县| 嘉兴市| 吉水县| 云和县| 祁连县| 甘泉县| 连城县| 彭阳县| 新宁县| 嘉定区| 芜湖县| 阿巴嘎旗| 贞丰县| 额济纳旗| 溆浦县| 遂昌县| 崇阳县| 若羌县| 阳泉市| 建阳市| 革吉县| 曲水县| 昌都县| 石林| 临城县| 安新县| 景宁|